P-499 Facilitators and barriers for home-based monitoring to time frozen embryo transfers in IVF
Abstract Study question What are the facilitators and barriers concerning the implementation of home-based monitoring for natural-cycle-frozen-embryo-transfer (NC-FET) from perspective of patients and healthcare providers in the Netherlands? Summary answer Most important facilitator was optimal preg...
| Published in: | Human Reproduction |
|---|---|
| Main Authors: | , , , , |
| Format: | Article in Journal/Newspaper |
| Language: | English |
| Published: |
Oxford University Press (OUP)
2022
|
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1093/humrep/deac105.121 https://academic.oup.com/humrep/article-pdf/37/Supplement_1/deac105.121/44306185/deac105.121.pdf |
| Summary: | Abstract Study question What are the facilitators and barriers concerning the implementation of home-based monitoring for natural-cycle-frozen-embryo-transfer (NC-FET) from perspective of patients and healthcare providers in the Netherlands? Summary answer Most important facilitator was optimal pregnancy chance, and most important barriers were risk of missing an ovulation for patients and laboratory capacity for healthcare providers. What is known already The number of FET cycles is increasing, mainly due to improvement in laboratory techniques. Based on current evidence, there is no difference in effectiveness when NC-FET is compared to artificial-cycle-FET (AC-FET) in ovulatory women. However, NC-FET is associated with lower risk of adverse obstetric and neonatal outcomes compared with AC-FET. NC-FET is performed based on ovulation monitoring, which can be hospital-based (ultrasounds and ovulation triggering) or home-based (LH-urine-tests). Home-based-monitoring has the advantage of being the most natural protocol for FET. A systematic approach for the implementation of home-based monitoring has to start with exploring the perspectives of all stakeholders. Study design, size, duration Both patients and healthcare providers participated in the present study. A panel of experts (n = 8) hypothesised on barriers and facilitators for the implementation of home-based-monitoring during the proposal phase of the Antarctica-2 randomised controlled trial. Two different questionnaires were developed in order to investigate facilitators and barriers for patients and for health care providers. Participants/materials, setting, methods The following stakeholders participated in the study: Patients – represented by the Dutch Patient Organisation for Couples with Fertility Problems. Healthcare providers – represented by gynaecologists (Netherlands Society of Obstetrics and Gynaecology), embryologists (Dutch Federation of Clinical Embryology) and fertility doctors. Based on our power analysis we aimed for 300 completed ... |
|---|